{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:36:49Z","timestamp":1790102209315,"version":"4.0.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T00:00:00Z","timestamp":1146614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2006,12,21]]},"DOI":"10.1007\/s10067-006-0315-1","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T04:31:04Z","timestamp":1146630664000},"page":"144-153","source":"Crossref","is-referenced-by-count":36,"title":["Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures"],"prefix":"10.1007","volume":"26","author":[{"given":"Margaret","family":"Gourlay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Franceschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniy","family":"Sheyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,5,3]]},"reference":[{"key":"315_CR1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200084","volume":"13","author":"TP Staa van","year":"2002","unstructured":"van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"315_CR2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP Staa van","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39:1383\u20131389","journal-title":"Rheumatology (Oxford)"},{"key":"315_CR3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.1780240705","volume":"24","author":"OS Gluck","year":"1981","unstructured":"Gluck OS, Murphy WA, Hahn TJ, Hahn B (1981) Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy. Arthritis Rheum 24:892\u2013898","journal-title":"Arthritis Rheum"},{"key":"315_CR4","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF00542348","volume":"25","author":"P Ruegsegger","year":"1983","unstructured":"Ruegsegger P, Medici TC, Anliker M (1983) Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25:615\u2013620","journal-title":"Eur J Clin Pharmacol"},{"key":"315_CR5","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1164\/rccm.200206-606OC","volume":"166","author":"RB Hubbard","year":"2002","unstructured":"Hubbard RB, Smith CJ, Smeeth L, Harrison TW, Tattersfield AE (2002) Inhaled corticosteroids and hip fracture: a population-based case-control study. Am J Respir Crit Care Med 166:1563\u20131566","journal-title":"Am J Respir Crit Care Med"},{"key":"315_CR6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa002304","volume":"345","author":"E Israel","year":"2001","unstructured":"Israel E, Banerjee T, Fitzmaurice G, Kotlov T, LaHive K, LeBoff M (2001) Effects of inhaled glucocorticoids in premenopausal women. N Engl J Med 345:941\u2013947","journal-title":"N Engl J Med"},{"key":"315_CR7","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(00)02138-3","volume":"355","author":"CA Wong","year":"2000","unstructured":"Wong CA, Walsh LJ, Smith CJ, Wisniewski A, Lewis S, Hubbard R, Cawte S, Green D, Pringle M, Tattersfield AE (2000) Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355:1399\u20131403","journal-title":"Lancet"},{"issue":"3","key":"315_CR8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.18553\/jmcp.2001.7.3.228","volume":"7","author":"B Ettinger","year":"2001","unstructured":"Ettinger B, Pressman A, Shah H (2001) Who bears responsibility for glucocorticoid-exposed patients in a large health maintenance organization. J Manag Care Pharm 7(3):228\u2013232","journal-title":"J Manag Care Pharm"},{"key":"315_CR9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","volume":"313","author":"LJ Walsh","year":"1996","unstructured":"Walsh LJ, Wong CA, Pringle M, Tattersfield AE (1996) Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ 313:344\u2013346","journal-title":"BMJ"},{"key":"315_CR10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.61.1.32","volume":"61","author":"B Gudbjornsson","year":"2002","unstructured":"Gudbjornsson B, Juliusson UI, Gudjonsson FV (2002) Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice. Ann Rheum Dis 61:32\u201336","journal-title":"Ann Rheum Dis"},{"key":"315_CR11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","volume":"19","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johansson H, Oden A, Johnell O, De Laet C, Melton IL, Tenenhouse A, Reeve J, Silman AJ, Pols HA, Eisman JA, McCloskey EV, Mellstrom D (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893\u2013899","journal-title":"J Bone Miner Res"},{"key":"315_CR12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/art.1780271205","volume":"27","author":"J Hooyman","year":"1984","unstructured":"Hooyman J, Melton L, Nelson A, O\u2019Fallon W, Riggs B (1984) Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 27:1353\u20131361","journal-title":"Arthritis Rheum"},{"key":"315_CR13","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.1780271203","volume":"27","author":"TR Dykman","year":"1984","unstructured":"Dykman TR, Haralson KM, Gluck OS, Murphy WA, Teitelbaum SL, Hahn TJ, Hahn BH (1984) Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 27:1336\u20131343","journal-title":"Arthritis Rheum"},{"key":"315_CR14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/rheumatology\/38.3.198","volume":"38","author":"JH Tobias","year":"1999","unstructured":"Tobias JH (1999) Management of steroid-induced osteoporosis: what is the current state of play? Rheumatology (Oxford) 38:198\u2013201","journal-title":"Rheumatology (Oxford)"},{"key":"315_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-136-1-200201010-00006","volume":"136","author":"A Everdingen van","year":"2002","unstructured":"van Everdingen A, Jacobs J, Siewertsz Van Reesema D, Bijlsma J (2002) Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 136:1\u201312","journal-title":"Ann Intern Med"},{"issue":"5","key":"315_CR16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.2110047","volume":"166","author":"LJ Walsh","year":"2002","unstructured":"Walsh LJ, Lewis SA, Wong CA, Cooper S, Oborne J, Cawte SA, Harrison T, Green DJ, Pringle M, Hubbard R, Tattersfield AE (2002) The impact of oral corticosteroid use on bone mineral density and vertebral fracture. Am J Respir Crit Care Med 166(5):691\u2013695","journal-title":"Am J Respir Crit Care Med"},{"key":"315_CR17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0002-9343(93)90057-V","volume":"94","author":"E Shane","year":"1993","unstructured":"Shane E, Rivas M, Silverberg S, Kim T, Taron R, Bilezikian J (1993) Osteoporosis after cardiac transplantation. Am J Med 94:257\u2013264","journal-title":"Am J Med"},{"key":"315_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00007890-200301150-00009","volume":"75","author":"T Mikuls","year":"2003","unstructured":"Mikuls T, Julian B, Bartolucci A, Saag K (2003) Bone mineral density changes within six months of renal transplantation. Transplantation 75:49\u201354","journal-title":"Transplantation"},{"key":"315_CR19","first-page":"683","volume":"18","author":"B Cortet","year":"2000","unstructured":"Cortet B, Guyot M-H, Solau E, Pigny P, Dumoulin F, Flipo R-M (2000) Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. Clin Exp Rheumatol 18:683\u2013690","journal-title":"Clin Exp Rheumatol"},{"key":"315_CR20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","volume":"344","author":"A Gough","year":"1994","unstructured":"Gough A, Lilley J, Eyre S, Holder R, Emery P (1994) Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344:23\u201327","journal-title":"Lancet"},{"key":"315_CR21","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","volume":"48","author":"TP Staa Van","year":"2003","unstructured":"Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224\u20133229","journal-title":"Arthritis Rheum"},{"key":"315_CR22","first-page":"2222","volume":"27","author":"R McKenzie","year":"2000","unstructured":"McKenzie R, Reynolds JC, O\u2019Fallon A, Dale J, Deloria M, Blackwelder W, Straus SE (2000) Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. J Rheumatol 27:2222\u20132226","journal-title":"J Rheumatol"},{"key":"315_CR23","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","volume":"119","author":"RF Laan","year":"1993","unstructured":"Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van\u2019t Hof MA, Lemmens JA (1993) Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med 119:963\u2013968","journal-title":"Ann Intern Med"},{"key":"315_CR24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1385\/JCD:7:4:359","volume":"7","author":"M Maricic","year":"2004","unstructured":"Maricic M, Gluck O (2004) Densitometry in glucocorticoid-induced osteoporosis. J Clin Densitom 7:359\u2013363","journal-title":"J Clin Densitom"},{"key":"315_CR25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/JBMR.041125","volume":"20","author":"F Ton","year":"2005","unstructured":"Ton F, Gunawardene S, Lee H, Neer R (2005) Effects of low-dose prednisone on bone metabolism. J Bone Miner Res 20:464\u2013470","journal-title":"J Bone Miner Res"},{"key":"315_CR26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Staa van","year":"2000","unstructured":"van Staa TP, Leufkens H, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993\u20131000","journal-title":"J Bone Miner Res"},{"key":"315_CR27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","volume":"96","author":"KG Saag","year":"1994","unstructured":"Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, Kohler JA, Furst DE (1994) Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 96:115\u2013123","journal-title":"Am J Med"},{"key":"315_CR28","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1001\/archinte.160.19.2917","volume":"160","author":"V Naganathan","year":"2000","unstructured":"Naganathan V, Jones G, Nash P, Nicholson G, Eisman J, Sambrook PN (2000) Vertebral fracture risk with long-term corticosteroid therapy: prevalence and relation to age, bone density, and corticosteroid use. Arch Intern Med 160:2917\u20132922","journal-title":"Arch Intern Med"},{"key":"315_CR29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/archinte.164.4.420","volume":"164","author":"R Orstavik","year":"2004","unstructured":"Orstavik R, Haugeberg G, Mowinckel P, Hoiseth A, Uhlig T, Falch J, Halse J, McCloskey E, Kvien T (2004) Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med 164:420\u2013425","journal-title":"Arch Intern Med"},{"key":"315_CR30","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(98)04835-1","volume":"353","author":"MA Baltzan","year":"1999","unstructured":"Baltzan MA, Suissa S, Bauer DC, Cummings SR (1999) Hip fractures attributable to corticosteroid use. Study of Osteoporotic Fractures Group. Lancet 353:1327","journal-title":"Lancet"},{"key":"315_CR31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.0306-5251.2001.bjcp.1385.x","volume":"51","author":"TP Staa van","year":"2001","unstructured":"van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG (2001) Public health impact of adverse bone effects of oral corticosteroids. Br J Clin Pharmacol 51:601\u2013607","journal-title":"Br J Clin Pharmacol"},{"key":"315_CR32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","volume":"332","author":"SR Cummings","year":"1995","unstructured":"Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, Cauley J, Black D, Vogt TM (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332:767\u2013773","journal-title":"N Engl J Med"},{"key":"315_CR33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s001980200078","volume":"13","author":"P Dargent-Molina","year":"2002","unstructured":"Dargent-Molina P, Douchin MN, Cormier C, Meunier PJ, Breart G (2002) Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study. Osteoporos Int 13:593\u2013599","journal-title":"Osteoporos Int"},{"issue":"3","key":"315_CR34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/qjmed\/hci029","volume":"98","author":"T Staa van","year":"2005","unstructured":"van Staa T, Geusens P, Pols H, de Laet C, Leufkens H, Cooper C (2005) A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM 98(3):191\u2013198","journal-title":"QJM"},{"key":"315_CR35","unstructured":"No authors listed (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1\u2013129"},{"key":"315_CR36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S8756-3282(01)00653-6","volume":"30","author":"JA Kanis","year":"2002","unstructured":"Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A (2002) Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone 30:251\u2013258","journal-title":"Bone"},{"key":"315_CR37","first-page":"1759","volume":"27","author":"I Lambrinoudaki","year":"2000","unstructured":"Lambrinoudaki I, Chan DT, Lau CS, Wong RW, Yeung SS, Kung AW (2000) Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study. J Rheumatol 27:1759\u20131765","journal-title":"J Rheumatol"},{"key":"315_CR38","first-page":"995","volume":"23","author":"JD Adachi","year":"1996","unstructured":"Adachi JD, Bensen WG, Bianchi F, Cividino A, Pillersdorf S, Sebaldt RJ, Tugwell P, Gordon M, Steele M, Webber C, Goldsmith CH (1996) Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3\u00a0year follow-up. J Rheumatol 23:995\u20131000","journal-title":"J Rheumatol"},{"key":"315_CR39","first-page":"CD000952","volume":"2","author":"J Homik","year":"2000","unstructured":"Homik J, Suarez-Almazor M, Shea B, Cranney A, Wells G, Tugwell P (2000) Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2:CD000952","journal-title":"Cochrane Database Syst Rev"},{"key":"315_CR40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00198-003-1570-5","volume":"15","author":"F Richy","year":"2004","unstructured":"Richy F, Ethgen O, Bruyere O, Reginster J-Y (2004) Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 15:301\u2013310","journal-title":"Osteoporos Int"},{"key":"315_CR41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00223-004-0005-4","volume":"76","author":"F Richy","year":"2005","unstructured":"Richy F, Schact E, Bruyere O, Ethgen O, Gourlay M, Reginster J-Y (2005) Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Calcif Tissue Int 76:176\u2013186","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"315_CR42","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/art.1780371014","volume":"37","author":"GM Hall","year":"1994","unstructured":"Hall GM, Daniels M, Doyle DV, Spector TD (1994) Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 37(10):1499\u20131505","journal-title":"Arthritis Rheum"},{"issue":"12","key":"315_CR43","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/rheumatology\/38.12.1239","volume":"38","author":"AW Kung","year":"1999","unstructured":"Kung AW, Chan TM, Lau CS, Wong RW, Yeung SS (1999) Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy. Rheumatology (Oxford) 38(12):1239\u20131244","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"315_CR44","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/thx.49.11.1099","volume":"49","author":"M Luengo","year":"1994","unstructured":"Luengo M, Pons F, Martinez de Osaba MJ, Picado C (1994) Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study. Thorax 49(11):1099\u20131102","journal-title":"Thorax"},{"issue":"2","key":"315_CR45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02565124","volume":"49","author":"L Montemurro","year":"1991","unstructured":"Montemurro L, Schiraldi G, Fraioli P, Tosi G, Riboldi A, Rizzato G (1991) Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calcif Tissue Int 49(2):71\u201376","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"315_CR46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/rheumatology\/36.2.255","volume":"36","author":"JD Adachi","year":"1997","unstructured":"Adachi JD, Bensen WG, Bell MJ, Bianchi FA, Cividino AA, Craig GL, Sturtridge WC, Sebaldt RJ, Steele M, Gordon M, Themeles E, Tugwell P, Roberts R, Gent M (1997) Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis. Br J Rheumatol 36(2):255\u2013259","journal-title":"Br J Rheumatol"},{"issue":"24","key":"315_CR47","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","volume":"328","author":"P Sambrook","year":"1993","unstructured":"Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J (1993) Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med 328(24):1747\u20131752","journal-title":"N Engl J Med"},{"issue":"11","key":"315_CR48","first-page":"1875","volume":"23","author":"A Kotaniemi","year":"1996","unstructured":"Kotaniemi A, Piirainen H, Paimela L, Leirisalo-Repo M, Uoti-Reilama K, Lahdentausta P, Ruotsalainen P, Kataja M, Vaisanen E, Kurki P (1996) Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy? J Rheumatol 23(11):1875\u20131879","journal-title":"J Rheumatol"},{"key":"315_CR49","first-page":"CD001983","volume":"2","author":"A Cranney","year":"2000","unstructured":"Cranney A, Welch V, Adachi J, Homik J, Shea B, Suarez-Almazor M, Tugwell P, Wells G (2000) Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2:CD001983","journal-title":"Cochrane Database Syst Rev"},{"key":"315_CR50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00296-004-0496-3","volume":"26","author":"F Tascioglu","year":"2005","unstructured":"Tascioglu F, Colak O, Armagan O, Alatas O, Oner C (2005) The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin. Rheumatol Int 26:21\u201329","journal-title":"Rheumatol Int"},{"key":"315_CR51","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1210\/jcem.83.4.4742","volume":"83","author":"C Roux","year":"1998","unstructured":"Roux C, Oriente P, Laan R, Hughes RA, Ittner J, Goemaere S, Di Munno O, Pouilles JM, Horlait S, Cortet B (1998) Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group. J Clin Endocrinol Metab 83:1128\u20131133","journal-title":"J Clin Endocrinol Metab"},{"key":"315_CR52","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","volume":"337","author":"JD Adachi","year":"1997","unstructured":"Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, Kendler DL, Lentle B, Olszynski W, Ste-Marie LG, Tenenhouse A, Chines AA (1997) Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 337:382\u2013387","journal-title":"N Engl J Med"},{"key":"315_CR53","first-page":"2424","volume":"27","author":"JD Adachi","year":"2000","unstructured":"Adachi JD, Roux C, Pitt PI, Cooper C, Moniz C, Dequeker J, Ioannidis G, Cawley MI, Jenkins EA, Walker-Bone KE, Pack S, Stephenson GF, Laan RF, Brown J, Geusens P (2000) A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss. J Rheumatol 27:2424\u20132431","journal-title":"J Rheumatol"},{"key":"315_CR54","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/thx.2003.013839","volume":"59","author":"I Campbell","year":"2004","unstructured":"Campbell I, Douglas J, Francis R, Prescott R, Reid D (2004) Five year study of etidronate and\/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and\/or inhaled glucocorticoids. Thorax 59:761\u2013768","journal-title":"Thorax"},{"key":"315_CR55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","volume":"44","author":"JD Adachi","year":"2001","unstructured":"Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E, Lane NE, Kaufman JM, Poubelle PE, Hawkins F, Correa-Rotter R, Menkes CJ, Rodriguez-Portales JA, Schnitzer TJ, Block JA, Wing J, McIlwain HH, Westhovens R, Brown J, Melo-Gomes JA, Gruber BL, Yanover MJ, Leite MO, Siminoski KG, Nevitt MC, Sharp JT, Malice MP, Dumortier T, Czachur M, Carofano W, Daifotis A (2001) Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum 44:202\u2013211","journal-title":"Arthritis Rheum"},{"key":"315_CR56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"KG Saag","year":"1998","unstructured":"Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339:292\u2013299","journal-title":"N Engl J Med"},{"key":"315_CR57","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s002239900352","volume":"61","author":"S Gonnelli","year":"1997","unstructured":"Gonnelli S, Rottoli P, Cepollaro C, Pondrelli C, Cappiello V, Vagliasindi M, Gennari C (1997) Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients. Calcif Tissue Int 61:382\u2013385","journal-title":"Calcif Tissue Int"},{"key":"315_CR58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002960000080","volume":"20","author":"L Yilmaz","year":"2001","unstructured":"Yilmaz L, Ozoran K, Gunduz OH, Ucan H, Yucel M (2001) Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids. Rheumatol Int 20:65\u201369","journal-title":"Rheumatol Int"},{"key":"315_CR59","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","volume":"67","author":"S Wallach","year":"2000","unstructured":"Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF, Doherty SM, Maricic M, Rosen C, Brown J, Barton I, Chines AA (2000) Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy. Calcif Tissue Int 67:277\u2013285","journal-title":"Calcif Tissue Int"},{"key":"315_CR60","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","volume":"15","author":"DM Reid","year":"2000","unstructured":"Reid DM, Hughes RA, Laan RF, Sacco-Gibson NA, Wenderoth DH, Adami S, Eusebio RA, Devogelaer JP (2000) Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res 15:1006\u20131013","journal-title":"J Bone Miner Res"},{"key":"315_CR61","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","volume":"42","author":"S Cohen","year":"1999","unstructured":"Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M, Zizic TM, Wallach S, Sewell KL, Lukert BP, Axelrod DW, Chines AA (1999) Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 42:2309\u20132318","journal-title":"Arthritis Rheum"},{"key":"315_CR62","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00198-003-1425-0","volume":"14","author":"J Ringe","year":"2003","unstructured":"Ringe J, Dorst A, Faber H, Ibach K, Sorenson F (2003) Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study. Osteoporos Int 14:801\u2013807","journal-title":"Osteoporos Int"},{"key":"315_CR63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1359\/jbmr.2001.16.1.104","volume":"16","author":"Y Boutsen","year":"2001","unstructured":"Boutsen Y, Jamart J, Esselinckx W, Devogelaer JP (2001) Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3\u00a0months, and calcium alone. J Bone Miner Res 16:104\u2013112","journal-title":"J Bone Miner Res"},{"key":"315_CR64","first-page":"CD001347","volume":"2","author":"J Homik","year":"2000","unstructured":"Homik J, Cranney A, Shea B, Tugwell P, Wells G, Adachi R, Suarez-Almazor M (2000) Bisphosphonates for steroid-induced osteoporosis. Cochrane Database Syst Rev 2:CD001347","journal-title":"Cochrane Database Syst Rev"},{"key":"315_CR65","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1359\/jbmr.2000.15.5.944","volume":"15","author":"NE Lane","year":"2000","unstructured":"Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD (2000) Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial. J Bone Miner Res 15:944\u2013951","journal-title":"J Bone Miner Res"},{"key":"315_CR66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11926-004-0085-1","volume":"6","author":"J Compston","year":"2004","unstructured":"Compston J (2004) US and UK guidelines for glucocorticoid-induced osteoporosis: similarities and differences. Curr Rheumatol Rep 6:66\u201369","journal-title":"Curr Rheumatol Rep"},{"key":"315_CR67","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","volume":"44","author":"American College of Rheumatology","year":"2001","unstructured":"American College of Rheumatology (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 44:1496\u20131503","journal-title":"Arthritis Rheum"},{"key":"315_CR68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00774-004-0596-x","volume":"23","author":"H Nawata","year":"2005","unstructured":"Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Zuzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 23:105\u2013109","journal-title":"J Bone Miner Metab"},{"key":"315_CR69","first-page":"793","volume":"30","author":"P Sambrook","year":"2001","unstructured":"Sambrook P, Diamond T, Ferris L, Fiatarone-Singh M, Flicker L, MacLennan A, Nowson C, O\u2019Neill S, Greville H (2001) Corticosteroid induced osteoporosis. Guidelines for treatment. Aust Fam Physician 30:793\u2013796","journal-title":"Aust Fam Physician"},{"key":"315_CR70","volume-title":"Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment","author":"Guidelines working group for the Bone and Tooth Society, National Osteoporosis Society and Royal College of Physicians","year":"2002","unstructured":"Guidelines working group for the Bone and Tooth Society, National Osteoporosis Society and Royal College of Physicians (2002) Glucocorticoid-induced osteoporosis: guidelines for prevention and treatment. Royal College of Physicians, London, UK"},{"key":"315_CR71","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/ard.2003.008060","volume":"63","author":"PP Geusens","year":"2004","unstructured":"Geusens PP, de Nijs RN, Lems WF, Laan RF, Struijs A, van Staa TP, Bijlsma JW (2004) Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology. Ann Rheum Dis 63:324\u2013325","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0315-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-006-0315-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0315-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T14:44:37Z","timestamp":1627310677000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-006-0315-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,3]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,12,21]]}},"alternative-id":["315"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0315-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,3]]}}}